Current Management of Onychomycosis

Kara S. Nunley, Lynn Cornelius

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Onychomycosis is the most common single cause of nail dystrophy and has a marked impact on quality of life. The availability of newer topical and systemic antifungal agents has improved our ability to effectively treat this condition. This article will review the most commonly used therapies and discuss the relative advantages and disadvantages of different treatment strategies.

Original languageEnglish
Pages (from-to)1211-1214
Number of pages4
JournalJournal of Hand Surgery
Issue number7
StatePublished - Sep 1 2008


  • Antifungal
  • fungal nail infections
  • nail dystrophy
  • onychomycosis

Fingerprint Dive into the research topics of 'Current Management of Onychomycosis'. Together they form a unique fingerprint.

Cite this